Rafael Vazquez-Duhalt

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Venues

ChemMedChem

Beilstein journal of nanotechnology

Journal of nanobiotechnology

Applied biochemistry and biotechnology

Université de Genève (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Université de Genève

Switzerland

PHD :: Physiologie Végétale

Publications

Jorge A Ontiveros-Robles, Francisca Villanueva-Flores, Karla Juarez-Moreno, Andrey Simakov, Rafael Vazquez-Duhalt
Antibody-Functionalized Copper Oxide Nanoparticles with Targeted Antibacterial Activity. ChemistryOpen 12 (5) (2023)
Kanchan Chauhan, Cindy N Olivares-Medina, Maria V Villagrana-Escareño, Karla Juárez-Moreno, Rubén D Cadena-Nava, Ana G Rodríguez-Hernández, Rafael Vazquez-Duhalt
Targeted Enzymatic VLP-Nanoreactors with β-Glucocerebrosidase Activity as Potential Enzyme Replacement Therapy for Gaucher's Disease. ChemMedChem 17 (19) (2022)
Jorge L Mejía-Méndez, Rafael Vazquez-Duhalt, Luis Ricardo Hernández, Eugenio Sánchez-Arreola, Horacio Bach
Virus-like Particles: Fundamentals and Biomedical Applications. International journal of molecular sciences 23 (15) (2022)
Pedro Gama, Ruben D Cadena-Nava, Karla Juarez-Moreno, Javier Pérez-Robles, Rafael Vazquez-Duhalt
Virus-Based Nanoreactors with GALT Activity for Classic Galactosemia Therapy. ChemMedChem 16 (9) (2021)
Alfredo Nuñez-Rivera, Pierrick G J Fournier, Danna L Arellano, Ana G Rodriguez-Hernandez, Rafael Vazquez-Duhalt, Ruben Dario Cadena-Nava
Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes. Beilstein journal of nanotechnology 11 (2020)
Kanchan Chauhan, Juan M Hernandez-Meza, Ana G Rodríguez-Hernández, Karla Juarez-Moreno, Prakhar Sengar, Rafael Vazquez-Duhalt
Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer. Journal of nanobiotechnology 16 (1) (2018)
Rina D Koyani, Rafael Vazquez-Duhalt
Enzymatic Activation of the Emerging Drug Resveratrol. Applied biochemistry and biotechnology 185 (1) (2017)

Rafael Vazquez-Duhalt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rafael Vazquez-Duhalt